BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, May 9, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 18, 2013
View Archived Issues
Researchers from the University of California present two novel ROR1-targeting therapies
Read More
LY-2928057 dose-dependently increases serum iron levels in vivo
Read More
Moberg reports interim data from phase II study of MOB-015 for onychomycosis
Read More
BioLineRx reports initial phase II data for BL-8040 in AML
Read More
Millennium Pharmaceuticals begins phase I study of TAK-659
Read More
arGEN-X reports findings from dose-escalation part of phase Ib study of ARGX-110
Read More
Retrophin agrees to acquire Kyalin Biosciences
Read More
Evotec and Yale establish DNA repair research collaboration
Read More
Chimeric antigen receptor therapy for pediatric ALL targets the TSLPR
Read More
Novel BTK inhibitors patented by Pharmascience
Read More
Chinese researchers prepare new SGLT2 inhibitors for diabetes
Read More
Ares Trading presents novel BACE1 inhibitors for neurodegenerative disorders
Read More
Navidea Biopharmaceuticals submits supplemental NDA to FDA for Lymphoseek
Read More
Scientists at Phenex Pharmaceuticals disclose new ROR-gamma modulators
Read More
AnaptysBio forms antibody development agreement with Momenta Pharmaceuticals
Read More
Capricor Therapeutics cleared to begin phase II portion of ALLSTAR trial
Read More
Hoffmann-La Roche synthesizes new PDE10A inhibitors for psychotic disorders
Read More
Studies in different species reveal developmental role for Lhx6 in schizophrenia
Read More
Boehringer Ingelheim patents new GPR40 agonists for diabetes
Read More
New NPFF1 receptor antagonists for pain designed by French group
Read More
MultiStem receives orphan drug designation in Europe
Read More
Novel radioligand described for imaging Abeta in AD
Read More
FDA approves Prosigna breast cancer gene signature assay
Read More
Ixico offers business update
Read More
PIVKA-II test kit for HCC launched in Japan
Read More
